Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)
Several studies have indicated that the administration of sermorelin acetate can lead to increased testosterone levels, promote body mass growth, and act as a fat burner
Kjeldsen-Kragh, J., Hvatum, M., Haugen, M., Forre, O
Human clinical trials show mixed, usually modest effects on body composition
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy, 2011 Mechanism of action: TESAMORELIN works by binding to GHRH receptors in the pituitary gland, stimulating the release of growth hormone
T Cells Nanoparticles encapsulating siRNA targeting c-Rel effectively suppress T helper 1 (Th1)/17 (Th17) cytokines [interferon gamma (IFN-), IL-17], halting disease progression in CIA models
